Skip to main content
. 2014 Dec;4(4):669–678. doi: 10.1086/678512

Table 4.

Pulmonary arterial hypertension (PAH) medications

Medication PAH–No CV (n = 43) PAH-CV (n = 75) P value
Phosphodiesterase 5 inhibitors 36 (84) 62 (83) 0.356
Endothelin receptor antagonists 21 (49) 39 (52) 0.289
Prostacyclin analogues 6 (14) 14 (19) 0.125
Combination therapy 19 (44) 38 (51) 0.176
Note

Data are no. (%). CV: cardiovascular risk factors.